Germany · Delayed Price · Currency is EUR Mereo BioPharma Group Statistics
Total Valuation
FRA:MAH0 has a market cap or net worth of EUR 251.87 million. The enterprise value is 210.32 million.
| Market Cap | 251.87M |
| Enterprise Value | 210.32M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.71% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 99.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 591.03 |
| PB Ratio | 6.34 |
| P/TBV Ratio | 6.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.54 |
Financial Position
The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.71 |
| Quick Ratio | 8.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -74.69 |
Financial Efficiency
Return on equity (ROE) is -69.79% and return on invested capital (ROIC) is -44.90%.
| Return on Equity (ROE) | -69.79% |
| Return on Assets (ROA) | -39.81% |
| Return on Invested Capital (ROIC) | -44.90% |
| Return on Capital Employed (ROCE) | -95.28% |
| Revenue Per Employee | 11,838 |
| Profits Per Employee | -984,241 |
| Employee Count | 36 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.84 |
| Relative Strength Index (RSI) | 49.29 |
| Average Volume (20 Days) | 103 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.85 |
Income Statement
In the last 12 months, FRA:MAH0 had revenue of EUR 426,150 and -35.43 million in losses. Loss per share was -0.22.
| Revenue | 426,150 |
| Gross Profit | 312,794 |
| Operating Income | -38.64M |
| Pretax Income | -35.43M |
| Net Income | -35.43M |
| EBITDA | -38.38M |
| EBIT | -38.64M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 41.51 million in cash and 338,363 in debt, giving a net cash position of 41.17 million.
| Cash & Cash Equivalents | 41.51M |
| Total Debt | 338,363 |
| Net Cash | 41.17M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 39.72M |
| Book Value Per Share | 0.25 |
| Working Capital | 39.54M |
Cash Flow
In the last 12 months, operating cash flow was -27.88 million and capital expenditures -17,046, giving a free cash flow of -27.89 million.
| Operating Cash Flow | -27.88M |
| Capital Expenditures | -17,046 |
| Free Cash Flow | -27.89M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.40% |
| Operating Margin | -9,067.80% |
| Pretax Margin | -8,314.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:MAH0 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.71% |
| Shareholder Yield | -9.71% |
| Earnings Yield | -14.07% |
| FCF Yield | -11.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:MAH0 has an Altman Z-Score of 22.26 and a Piotroski F-Score of 2.
| Altman Z-Score | 22.26 |
| Piotroski F-Score | 2 |